Wan, Huijuan
Liu, Qi
Chen, Chao
Dong, Wenyu
Wang, Shengsong
Shi, Weixiong
Li, Chengyu
Ren, Jiechuan
Wang, Zhanxiang
Cui, Tao
Shao, Xiaoqiu http://orcid.org/0000-0001-5798-7115
Funding for this research was provided by:
Epilepsy research fund of the China Association Against Epilepsy (CB-2022-026)
Xiamen Municipal Health Commission,Xiamen Municipal Bureau of Science and Technology (3502Z20209005)
Article History
Received: 6 October 2023
Accepted: 8 November 2023
First Online: 29 November 2023
Declarations
:
: None of the authors has any conflict of interest to disclose.
: This study was performed according to the principles of the Declaration of Helsinki and was approved by the medical ethics committees of Beijing Tiantan Hospital (no. KYSQ2023-239-01) and the First Affiliated Hospital affiliated with Xiamen University (no. KY2022-035). Informed consent was obtained from the patients upon admission to the hospital for using their anonymized clinical data for scientific investigations and publication. The visual rating scales (the Fazekas scale, total CSVD burden score, and GCA grade) used in this study have been developed and widely used in the past [CitationRef removed–CitationRef removed]. These scales are allowed to be publicly available, and the original authors have provided researchers with permission to use the scales.